- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00920270
Nebulized Colistin for Hospital-Acquired Pneumonia
June 11, 2009 updated by: Mahidol University
Efficacy and Safety of Nebulized Colistin for Adjunctive Therapy of Hospital-Acquired Pneumonia Caused by Gram Negative Bacteria
Nebulized Colistin for Adjunctive Therapy of Hospital-Acquired Pneumonia caused by Gram Negative Bacteria should be more effective than conventional therapy
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Randomized Controlled Clinical Trial in hospitalized adult patients with hospital-acquired pneumonia.
The patients are allocated to conventional group or nebulized colistin group.
The conventional group receives conventional antibiotics whereas the nebulized colistin group receives nebulized colistin in addition to conventional antibiotics.
The outcomes are clinical response and microbiological responses.
Study Type
Interventional
Enrollment (Anticipated)
140
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bangkok, Thailand, 10700
- Siriraj Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult (age>18 years) hospitalized patient with hospital-acquired pneumonia due to Gram negative bacteria
Exclusion Criteria:
- pregnancy
- lactating woman
- colistin allergy
- severe renal impairment
- epilepsy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: antibiotic
conventional antibiotics
|
conventional parenteral antibiotics
|
Experimental: colistin group
nebulized colistin
|
nebulized colistin 75 mg every 12 hours
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Clinical response
Time Frame: 14 days after Treatment
|
14 days after Treatment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Microbiological response and safety
Time Frame: 14 days after treatment
|
14 days after treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2006
Primary Completion (Anticipated)
March 1, 2010
Study Registration Dates
First Submitted
June 11, 2009
First Submitted That Met QC Criteria
June 11, 2009
First Posted (Estimate)
June 15, 2009
Study Record Updates
Last Update Posted (Estimate)
June 15, 2009
Last Update Submitted That Met QC Criteria
June 11, 2009
Last Verified
June 1, 2006
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Siriraj CEU 50-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Department of Health and Human ServicesNot yet recruitingHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
ShionogiCompletedHospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)Israel, Spain, United States, Belgium, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Japan, Latvia, Philippines, Puerto Rico, Russian Federation, Serbia, Taiwan, Ukraine
-
Methodist Health SystemCompletedHospital-acquired Pneumonia | Ventilator-associated PneumoniaUnited States
Clinical Trials on antibiotics
-
Eastern Virginia Medical SchoolNot yet recruitingPreterm Premature Rupture of Membrane
-
Centre Hospitalier Universitaire, AmiensRecruiting
-
Rush University Medical CenterRothman Institute OrthopaedicsCompletedArthroplasty | InfectionUnited States
-
Atlantic Health SystemRecruitingStress Urinary Incontinence | Postoperative Urinary Tract Infection | Urethral BulkingUnited States
-
Southern Illinois UniversityWashington University School of MedicineCompleted
-
Prisma Health-UpstateTerminated
-
Brigham and Women's HospitalDana-Farber Cancer InstituteNot yet recruitingFebrile Neutropenia | Hematologic Malignancy | Antibiotic Stewardship
-
Washington University School of MedicineSt. Louis UniversityTerminatedThe Primary Outcome of This Study Will be the Rate of EndometritisUnited States
-
Children's Hospital of PhiladelphiaCompletedAcute Otitis Media | Acute Sinusitis | Group A Streptococcal PharyngitisUnited States
-
Mount Sinai Hospital, CanadaUnity Health Toronto; The Ottawa Hospital; Sault Area Hospital; Michael Garron...RecruitingInfectious DiseaseCanada